FDA Drug Application (022177) for STAVUDINE; LAMIVUDINE; NEVIRAPINE by STRIDES ACROLAB

Back to FDA Applications sponsored by STRIDES ACROLAB

Application Number022177
Product Number001
FormTABLET; ORAL
Dosage30MG; 150MG; 200MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameSTAVUDINE; LAMIVUDINE; NEVIRAPINE
Active IngredientSTAVUDINE; LAMIVUDINE; NEVIRAPINE

Active IngredientCount
List of drugs with Active Ingredient LAMIVUDINE39
List of drugs with Active Ingredient NEVIRAPINE17
List of drugs with Active Ingredient STAVUDINE11


Back to FDA Applications sponsored by STRIDES ACROLAB